Table of Contents
<< Previous Issue | Jan 2017 (Vol: 2017, Issue: 1) | Next Issue >> |
- Section: Licensing
-
Akebia and Otsuka partner for vadadustat with a deal worth over US$1 B
-
Novartis Bolsters NASH Pipeline with a Deal with Conatus
- Section: Mergers & Acquisitions
-
Sumitomo Dainippon Pharma Enriches Oncology Pipeline with Tolero Acquisition
-
Takeda Acquires Ariad for US$5.2 B to Add Depth to Oncology Portfolio
- Section: Research & Development
-
Purdue Leverages Exicure’s SNA™ Technology Platform to Diversify its Portfolio
-
Pfizer Enriches Oncology Franchise Through BioInvent’s TAM Targeting Antibodies
-
Pieris and Servier Collaborate on Immuno-Oncology Drug Development